-
GLUE Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Monte Rosa Therapeutics (GLUE)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 130.48 mm | 130.48 mm | 130.48 mm | 130.48 mm | 130.48 mm | 130.48 mm |
Cash burn (monthly) | (no burn) | (no burn) | 8.84 mm | 10.75 mm | 7.00 mm | 4.77 mm |
Cash used (since last report) | n/a | n/a | 46.90 mm | 57.01 mm | 37.12 mm | 25.32 mm |
Cash remaining | n/a | n/a | 83.58 mm | 73.48 mm | 93.37 mm | 105.16 mm |
Runway (months of cash) | n/a | n/a | 9.5 | 6.8 | 13.3 | 22.0 |
13F holders | Current |
---|---|
Total holders | 107 |
Opened positions | 34 |
Closed positions | 12 |
Increased positions | 36 |
Reduced positions | 18 |
13F shares | Current |
---|---|
Total value | 370.95 bn |
Total shares | 72.76 mm |
Total puts | 15.90 k |
Total calls | 275.80 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
NEA Management | 7.69 mm | $53.38 bn |
New Enterprise Associates 17 | 7.69 mm | $30.62 mm |
T. Rowe Price | 7.12 mm | $49.39 mm |
Versant Venture Management | 5.65 mm | $39.23 bn |
FMR | 5.55 mm | $38.51 bn |
Baker Bros. Advisors | 4.92 mm | $34.12 bn |
Avoro Capital Advisors | 4.35 mm | $30.15 bn |
Versant Venture Capital VI | 4.08 mm | $37.45 mm |
BlackRock | 3.84 mm | $26.65 bn |
Vanguard | 3.16 mm | $21.91 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 25 | Edmund Dunn | Common Stock | Grant | Acquire A | No | No | 0 | 11,850 | 0.00 | 25,794 |
2 Jan 25 | Edmund Dunn | Stock Option Common Stock | Grant | Acquire A | No | No | 7.11 | 53,400 | 379.67 k | 53,400 |
2 Jan 25 | Filip Janku | Common Stock | Grant | Acquire A | No | No | 0 | 36,000 | 0.00 | 45,189 |
2 Jan 25 | Filip Janku | Stock Option Common Stock | Grant | Acquire A | No | No | 7.11 | 161,000 | 1.14 mm | 161,000 |
2 Jan 25 | Markus Warmuth | Common Stock | Grant | Acquire A | No | No | 0 | 128,000 | 0.00 | 544,538 |
2 Jan 25 | Markus Warmuth | Stock Option Common Stock | Grant | Acquire A | No | No | 7.11 | 575,000 | 4.09 mm | 575,000 |
2 Jan 25 | Sharon Townson | Common Stock | Grant | Acquire A | No | No | 0 | 36,000 | 0.00 | 36,000 |
2 Jan 25 | Sharon Townson | Stock Option Common Stock | Grant | Acquire A | No | No | 7.11 | 161,000 | 1.14 mm | 161,000 |
2 Jan 25 | Philip Nickson | Common Stock | Grant | Acquire A | No | No | 0 | 36,000 | 0.00 | 36,000 |
2 Jan 25 | Philip Nickson | Stock Option Common Stock | Grant | Acquire A | No | No | 7.11 | 161,000 | 1.14 mm | 161,000 |